Financial support and resources available for businesses impacted by COVID-19.

Support for businesses impacted by COVID-19.

MethylGene Inc.

MethylGene is a biopharmaceutical company focused on the discovery, development and commercialization of novel and proprietary enzyme inhibitors for the treatment of cancer and infectious diseases.

Investment year: 2005
Industry sector: Biotechnology
Region: Quebec
Follow MethylGene Inc.
BDC Venture Capital Partner

Phil Anzarut